Xiaoling Cai

4.1k total citations
185 papers, 2.7k citations indexed

About

Xiaoling Cai is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Xiaoling Cai has authored 185 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Endocrinology, Diabetes and Metabolism, 56 papers in Molecular Biology and 49 papers in Surgery. Recurrent topics in Xiaoling Cai's work include Diabetes Treatment and Management (77 papers), Diabetes Management and Research (42 papers) and Metabolism, Diabetes, and Cancer (33 papers). Xiaoling Cai is often cited by papers focused on Diabetes Treatment and Management (77 papers), Diabetes Management and Research (42 papers) and Metabolism, Diabetes, and Cancer (33 papers). Xiaoling Cai collaborates with scholars based in China, Hong Kong and United States. Xiaoling Cai's co-authors include Linong Ji, Wenjia Yang, Xueyao Han, Linong Ji, Xueying Gao, Fang Lv, Yifei Chen, Yongcheng Lin, Chu Lin and Zhigang She and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Xiaoling Cai

174 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoling Cai China	27	1.1k	697	550	439	309	185	2.7k
Maria Notarnicola Italy	34	443 0.4×	1.3k 1.9×	459 0.8×	619 1.4×	539 1.7×	152	3.6k
Rosaria Vincenza Giglio Italy	30	701 0.6×	582 0.8×	209 0.4×	560 1.3×	544 1.8×	91	2.5k
Choon Hee Chung South Korea	39	1.3k 1.2×	1.4k 2.1×	197 0.4×	560 1.3×	914 3.0×	178	4.4k
Maria Gabriella Caruso Italy	33	425 0.4×	1.1k 1.5×	449 0.8×	490 1.1×	409 1.3×	112	3.3k
György Paragh Hungary	29	401 0.4×	547 0.8×	377 0.7×	504 1.1×	298 1.0×	136	2.7k
Shui‐Ping Zhao China	35	1.0k 1.0×	1.0k 1.4×	226 0.4×	1.5k 3.5×	722 2.3×	235	4.3k
Jing Gong China	31	278 0.3×	1.0k 1.5×	374 0.7×	336 0.8×	302 1.0×	101	2.9k
Nanwei Tong China	25	1.1k 1.0×	779 1.1×	144 0.3×	407 0.9×	300 1.0×	124	2.4k
Kepa B. Uribe Spain	17	869 0.8×	793 1.1×	120 0.2×	655 1.5×	335 1.1×	42	2.6k
Asier Benito‐Vicente Spain	19	973 0.9×	913 1.3×	135 0.2×	993 2.3×	404 1.3×	40	3.2k

Countries citing papers authored by Xiaoling Cai

Since Specialization

Citations

This map shows the geographic impact of Xiaoling Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Cai more than expected).

Fields of papers citing papers by Xiaoling Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Cai. The network helps show where Xiaoling Cai may publish in the future.

Co-authorship network of co-authors of Xiaoling Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Cai. A scholar is included among the top collaborators of Xiaoling Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Cai. Xiaoling Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Xiaoling, Chu Lin, Jing Wu, et al.. (2025). Comparison of glucose fluctuation between metformin combined with acarbose or sitagliptin in Chinese patients with type 2 diabetes: A multicenter, randomized, active-controlled, open-label, parallel design clinical trial. Chinese Medical Journal. 138(9). 1116–1125.

Liu, Wei, Xiaoling Cai, Yu Zhu, et al.. (2025). Metabolic syndrome in type 1 diabetes: higher time above range and glycemic variability revealed by continuous glucose monitoring (CGM). Diabetology & Metabolic Syndrome. 17(1). 49–49. 2 indexed citations

Lin, Chu, et al.. (2025). Weight Loss, Obesity Medication, and Risk of Obesity‐Associated Cancer: A Meta‐Analysis of Randomized Controlled Trials. Obesity.

Mao, Bin, Xiaoling Cai, Na Lin, et al.. (2025). Congenital muscular dystrophies and myopathies: the leading cause of genetic muscular disorders in eleven Chinese families. BMC Musculoskeletal Disorders. 26(1). 51–51. 1 indexed citations

Cai, Xiaoling, Wen‐Jia Yang, Bo Feng, et al.. (2025). Real-World Multicenter Registry to Determine Management and Quality of Care of Patients with Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases in China (iCaReMe China). Advances in Therapy. 42(3). 1600–1609.

Lin, Chu, et al.. (2025). Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic review and meta-analysis of randomized controlled trials. Expert Review of Clinical Pharmacology. 18(3). 165–173. 1 indexed citations

Liu, Wei, Ying Gao, Rui Zhang, et al.. (2024). Predictive value of postprandial C-peptide for utilizing multiple daily injection therapy in type 2 diabetes. Endocrine. 85(3). 1162–1169.

Guo, Chengcheng, Zonglin Li, Xiaoling Cai, et al.. (2024). Mulberry Twig Alkaloids Improved the Progression of Metabolic-Associated Fatty Liver Disease in High-Fat Diet-Induced Obese Mice by Regulating the PGC1α/PPARα and KEAP1/NRF2 Pathways. Pharmaceuticals. 17(10). 1287–1287. 3 indexed citations

Lv, Fang, et al.. (2024). Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice. Pharmaceuticals. 17(12). 1655–1655. 9 indexed citations

10.

Liu, Wei, Shenda Hong, Yu Zhu, et al.. (2024). Development and external validation of an algorithm for self‐identification of risk for microvascular complications in patients with type 1 diabetes. Diabetes Obesity and Metabolism. 27(2). 740–749. 1 indexed citations

11.

Wang, Liying, et al.. (2024). The Effectiveness of Mixed Food Attractant for Managing Helicoverpa armigera (Hübner) and Agrotis ipsilon (Hufnagel) in Peanut Fields. Agronomy. 14(5). 986–986. 2 indexed citations

12.

Lin, Chu, et al.. (2024). Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials. Alzheimer s Research & Therapy. 16(1). 272–272. 11 indexed citations

13.

Lv, Fang, Xiaoling Cai, Yufeng Li, et al.. (2023). Sensitivity to thyroid hormone and risk of components of metabolic syndrome in a Chinese euthyroid population. Journal of Diabetes. 15(10). 900–910. 18 indexed citations

14.

Zhang, Rui, Xiaoling Cai, Chu Lin, et al.. (2023). Primary aldosteronism and obstructive sleep apnea: A meta-analysis of prevalence and metabolic characteristics. Sleep Medicine. 114. 8–14. 4 indexed citations

15.

Lin, Xueqin, et al.. (2022). Extranodal natural killer/T-cell lymphoma invading a patient’s heart: A rare case report and literature review. Frontiers in Oncology. 12. 1011894–1011894. 2 indexed citations

16.

Lv, Fang, Xiaoling Cai, Dayi Hu, et al.. (2019). Characteristics of Newly Diagnosed Type 2 Diabetes in Chinese Older Adults: A National Prospective Cohort Study. Journal of Diabetes Research. 2019. 1–9. 10 indexed citations

17.

Cai, Xiaoling, Xueying Gao, Wenjia Yang, & Linong Ji. (2018). Disparities in the Efficacy of Metformin in Combination with Dipeptidyl Peptidase-4 Inhibitor as Initial Treatment Stratified by Dosage and Ethnicity: A Meta-Analysis. Diabetes Technology & Therapeutics. 20(10). 704–714. 2 indexed citations

18.

Cai, Xiaoling, Liwei Ji, Yifei Chen, et al.. (2017). Comparisons of weight changes between sodium‐glucose cotransporter 2 inhibitors treatment and glucagon‐like peptide‐1 analogs treatment in type 2 diabetes patients: A meta‐analysis. Journal of Diabetes Investigation. 8(4). 510–517. 43 indexed citations

19.

Ji, Linong, et al.. (2014). Understanding the standard of care in the treatment of type 2 diabetes in China: results from a national survey. Chinese Medical Journal. 127(20). 3524–3529. 26 indexed citations

20.

Cai, Xiaoling, et al.. (2010). Cytotoxic and topoisomerase I inhibitory activities from extracts of endophytic fungi isolated from mangrove plants in Zhuhai, China. Journal of Ecology and the Natural Environment. 2(2). 17–24. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact